HOME >> MEDICINE >> NEWS
Should nurses conduct breast cancer follow-up visits?

Hamburg, Germany: Women who have been treated for breast cancer find follow-up visits to their oncologists unsatisfactory and not reassuring, according to research carried out in Sweden.

Ingrid Kssler, president of the Swedish Association of Breast Cancer Societies, told the 4th European Breast Cancer Conference in Hamburg today (Thursday 18 March) that the format of follow-up visits needed to be changed and that research should be carried out into the efficacy of specialist nurses conducting the follow-ups.

Ms Kssler sent questionnaires to 1,200 members of three different local breast cancer organizations within the Swedish Breast Cancer Association, and also distributed it to participants in an Internet discussion forum. She received over 600 replies.

"The majority of the women preferred to go to a breast centre for follow-up visits rather than to their GP," said Ms Kssler. "However, they indicated that the follow-up examinations were hurried, investigations were not reassuring and some women reported a lack of continuity as they saw different oncologists at each visit. Many women felt there was no opportunity to ask questions, express emotional concerns or talk about their social situation.

"Other research has found that 70 to 80 per cent of recurrences have been detected by the patients themselves and this casts doubt on the effectiveness of follow-up visits with oncologists and surgeons and the use of routine investigations.

"It is important that the follow-up visits are changed to meet patients' ongoing needs better."

The rationale behind follow-up visits after primary treatment for breast cancer is that early detection of a recurrence leads to a better outcome, that women get a sense of psychological security and satisfaction from the visit, and that the data collected are useful for quality assurance. However, the visits are expensive and Ms Kssler said that if they are also ineffective in achieving their a
'"/>

Contact: Emma Mason
wordmason@aol.com
49-403-569-3625
Federation of European Cancer Societies
18-Mar-2004


Page: 1 2

Related medicine news :

1. Should medical students have earlier contact with patients?
2. Should compulsory screening of immigrants be part of UK public health policy?
3. Should the standard guidelines for assessing prostate cancer control be changed?
4. Should living liver donation be available in the NHS?
5. Should ambulance crews perform emergency breathing procedure?
6. C-reactive proteins: Should everyone be tested?
7. Should people with dementia be electronically tagged?
8. Should we help to create disabled babies?
9. Should people with diabetes sleep with the lights on?
10. Should women be screened for domestic violence?
11. Should banks be liable for pollution caused by companies that borrow from them?

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Should nurses conduct breast cancer follow visits

(Date:4/25/2015)... Providenciales, Turks and Caicos Islands, BWI (PRWEB) April 25, ... Providenciales International Airport (PLS) has celebrated three months of ... since reopening on January 5, 2015. , As ... phases, the interior of Providenciales airport was completely redesigned ... area has quickened up the process of getting out ...
(Date:4/25/2015)... April 25, 2015 On Friday, April ... RFID Journal’s annual Best Implementation Award. This award ... the best use of RFID technology to improve its ... the company that best demonstrates how RFID is delivering ... at RFID Journal Live! 2015 in San Diego, the ...
(Date:4/24/2015)... AK (PRWEB) April 24, 2015 As ... (#MOTMC2015) and the unique sacrifices of these young men ... for Service members, Veterans and their Families” presents a ... training is designed to gain a better understanding of ... health and wellness. For those – civilian and military ...
(Date:4/24/2015)... The 1975 have had an intense ... globe to theaters, festivals and TV performances. Now that they’ve ... their label, Dirty Hit Records, to provide clean drinking water ... launched Cadence & Cause website, this four-piece has ... and a signed photo card. Entries from this sweepstakes ...
(Date:4/24/2015)... Anchor Health Administrators (Anchor), specialists in Long-Term ... their exclusive agreement with LTC Solutions for All LLC ... partner. , Anchor has more than 18 years of ... associations, and is currently the designated advocate for the ... Insurance member benefit. , “I am very pleased to ...
Breaking Medicine News(10 mins):Health News:The Tuscany on Grace Bay Celebrates Providenciales Airport Expansion With Summer Specials to Travelers! 2Health News:Seeonic’s Industry Leading Technology Powers Interstate Batteries to Winning Award 2Health News:Coalition Presents Resiliency Training to Raise Awareness during Month of the Military Child (#MOTMC2015) 2Health News:Internationally Recognized British Indie Rock Outfit The 1975 Partner with Cadence & Cause to Provide Clean Drinking Water to Those in Need 2
(Date:4/24/2015)... , April 24, 2015  Lannett Company, Inc. (NYSE: ... and increased its five-year revolving credit facility to $120 ... accordion feature that will allow the company to increase ... $30.0 million, subject to securing additional commitments from existing ... the credit facility remains December 18, 2018.   ...
(Date:4/24/2015)... 2015 Hospira, Inc. (NYSE: ... biosimilar therapies, spoke about the importance of extrapolation in ... Association (EGA) annual European Biosimilars Group conference in ... announced the publication of a pivotal white paper titled, ... promise of biosimilars." Speaking at the ...
(Date:4/24/2015)... April 24, 2015  Blueprint Medicines today announced ... and potent inhibitor of fibroblast growth factor receptor ... of hepatocellular carcinoma (HCC) that are dependent on ... induced complete tumor regression in a subset of ... at the highest dose levels. These data will ...
Breaking Medicine Technology:Lannett Expands Revolving Credit Facility To $120 Million 2Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 2Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 3Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 4Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 5Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 6Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 7Blueprint Medicines Presents New Preclinical Data Demonstrating Its Drug Candidate BLU-554 Induces Significant Tumor Regression in Models of Hepatocellular Carcinoma 2Blueprint Medicines Presents New Preclinical Data Demonstrating Its Drug Candidate BLU-554 Induces Significant Tumor Regression in Models of Hepatocellular Carcinoma 3
Cached News: